These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7200652)

  • 1. [Results of local transurethral high frequency hyperthermia in bladder carcinoma (author's transl)].
    Bichler KH; Harzmann R; Flachenecker G; Fastenmeier K; Altenähr E; Gericke D; Flüchter SH
    Urologe A; 1982 Jan; 21(1):12-9. PubMed ID: 7200652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of hyperthermia on the bladder carcinomas of the dog (author's transl)].
    Rigotti E; Fontana D; Negri GL; Palestro G; Randone DF; Borgno M
    J Urol Nephrol (Paris); 1977 Mar; 83(3):175-84. PubMed ID: 853554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
    Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
    J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local high-frequency hyperthermia of the Brown-Pearce carcinoma in the urinary bladder of rabbits (author's transl)].
    Harzmann R; Bichler KH; Gerichke D; Altenähr E; Dietzel F; Erdmann D
    Urologe A; 1978 Mar; 17(2):130-4. PubMed ID: 636119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin hypogastric artery infusion combined with hyperthermia therapy for transitional cell carcinoma of the bladder.
    Jacobs SC; Maddison FE; Lawson RK
    Cancer Treat Rep; 1981; 65(9-10):891-3. PubMed ID: 7273025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in transurethral resection of bladder carcinoma (author's transl)].
    Bichler KH; Harzmann R; Flüchter SH; Erdmann W
    Urologe A; 1982 Jan; 21(1):3-8. PubMed ID: 7200655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy.
    Weiss C; von Römer F; Capalbo G; Ott OJ; Wittlinger M; Krause SF; Sauer R; Rödel C; Rödel F
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1455-60. PubMed ID: 19231102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment.
    Serretta V; Ruggirello A; Dispensa N; Allegro R; Aragona F; Melloni D
    J Urol; 2008 Sep; 180(3):886-90; discussion 891. PubMed ID: 18635223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
    Serretta V; Lo Greco G; Pavone C; Pavone-Macaluso M
    J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of recurrence of T1G3 transitional cell carcinoma of bladder].
    Zhang YS; Li HZ; Zhang RQ; Shi BB
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1305-8. PubMed ID: 16796897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
    Flamm J; Grof F
    Wien Med Wochenschr; 1981 Oct; 131(20):501-6. PubMed ID: 7314632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.